medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2006, Number S1

<< Back Next >>

Ann Hepatol 2006; 5 (S1)

Module ll
Diagnosis of patients with suspected chronic hepatitis C virus infection

Hevia UFJ

Language: English
References: 12
Page: 15-18
PDF size: 47.82 Kb.


Text Extraction

When a patient is suspected of chronic hepatitis C virus (HCV) infection, the following examinations should be conducted.

I. An epidemiological study should be conducted to determine if the patient has an increased risk of HCV infection. Recommendations for routine HCV testing have been published by the CDC (Center for Disease Control), AASLD (American Association for the Study of Liver Diseases), and NIH (National Institute of Health).


REFERENCES

  1. Screening for hepatitis C virus infection in adults: recommendation statement. Ann Intern Med 2004; 140: 462.

  2. Calonge N, Randhawa G. The meaning of the U.S. Preventive Services Task Force grade I recommendation: screening for hepatitis C virus infection. Ann Intern Med 2004; 141: 718.

  3. Alter MJ, Seeff LB, Bacon BR, et al. Testing for hepatitis C virus infection should be routine for persons at increased risk for infection. Ann Intern Med 2004; 141: 715.

  4. Sheth SG, Flamm SL, Gordon FD, Chopra S. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol 1998; 93: 44.

  5. Marcellin P, Levy S, Benhamou JP, Erlinger S. Management of the asymptomatic HCV carrier with normal ALT levels. Viral Hepatitis Rev 1996; 2: 227.

  6. Scheuer PJ, Asharafzadeh P, Sherlock S, et al. The pathology of hepatitis C. Hepatology 1992; 15: 567.

  7. Gretch DR. Diagnostic tests for hepatitis C. Hepatology 1997; 26: 43S.

  8. Busch MP, Tobler LH, Tegtmeier G, et al. Use of third-generation hepatitis C virus (HCV) enzyme immunoassay (EIA) to resolve second-generation HCV EIA- reactive and second-generation recombinant immunoblot assay-indeterminate blood samples: data to support current Food and Drug Administration guidance on HCV lookback. Transfusion 2000; 40: 10.

  9. Uyttendaele S, Claeys H, Mertens W, et al. Evaluation of thirdgeneration screening and confirmatory assays for HCV antibodies. Vox Sang 1994; 66: 122.

  10. Pawlotsky JM, Lonjon I, Hezode C, et al. What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories? Hepatology 1998; 27: 1700.

  11. Gretch DR, dela Rosa C. Carithers RL Jr, et al. Assessment of hepatitis C viremia using molecular amplification technologies: correlations and clinical implications. Ann Intern Med 1995; 123: 321.

  12. Martinot-Peignoux M, Boyer N, Le Breton V, et al. A new step toward standardization of serum hepatitis C virus-RNA quantification in patients with chronic hepatitis C. Hepatology 2000; 31: 726.




2020     |     www.medigraphic.com